Quality Improvement Intervention for Universal Lipid Screening in Children Aged 9 to 11 Years

Clin Pediatr (Phila). 2019 Dec;58(14):1528-1533. doi: 10.1177/0009922819884403. Epub 2019 Oct 22.

Abstract

We performed a quality improvement intervention to increase universal lipid screening in well-child visits (age 9 to 11 years): 12-month preintervention; phase 1 (8 months) with provider education, group monthly chart review with feedback, and electronic health record cues to order lipids; and phase 2 (16 months) with electronic health record cues and examination room phlebotomy. Outcomes were compared with clinics having no intervention. In phase 1, immediate treatment effect on the regression line for provider behavior (proportion of visits with lipids ordered) showed 34% increase in intervention and 7% decrease in comparison clinics; patient behavior (phlebotomy completed) showed 19% increase in intervention and 5% decrease in comparison clinics. At the beginning of phase 2, the intervention clinic had average 44% orders entered and 33% phlebotomy completed per well-child visit, and these proportions were maintained. Provider education and chart review with feedback were associated with the greatest gains in outcomes.

Keywords: cardiovascular; cholesterol; pediatrics; prevention.

MeSH terms

  • Biomarkers / blood
  • Child
  • Child Health / standards*
  • Female
  • Humans
  • Lipids / blood*
  • Male
  • Mass Screening / standards*
  • Pediatrics / standards
  • Physical Examination / standards
  • Quality Improvement*
  • Quality Indicators, Health Care

Substances

  • Biomarkers
  • Lipids